Abstract:

The pandemic brought many uncertainties about both the disease itself and the health system. Due to the high rate of transmission, the Covid-19 pandemic has caused individuals to experience problems in accessing health services not only for Covid-19 but also for other diseases wether chronic or acute. In the stages of struggling with the pandemic, conducting economic evaluation studies on Covid-19 was seen as important, taking into account the uncertainties and access issues encountered, in order to guide decision makers for rational decision-making and to use resources effectively and efficiently. This study aims systematically review the economic evaluation studies for the diagnosis, treatment, and control of Covid-19 disease. PubMed, Scopus, Web of Science and ULAKBİM databases were searched from December 2019 to July 2021 to identify the literature on economic evaluation studies related to Covid-19. As a result of the systematic search, 362 articles were identified as a result of the search made in the relevant databases. After the repetitive entries were removed, title and abstract scanning were performed, and 22 publications that met the inclusion criteria were examined within the scope of the study. It was observed that 68.18% of the studies were published in 2021 and 31.81% in 2020. 81.8% of the published studies have been conducted with cost-effectiveness, 9.09% with cost-benefit, and 4.54% with cost minimization and cost-utility analysis. The majority of the countries where the studies were conducted were in high-income countries, in 2021 and cost-effectiveness analysis. The subject of these studies is mostly related to screening and diagnostic tests for Covid-19 disease. There wasn't any study detected conducted in Turkey on the subject. More research on this particular subject is required in the future.

Keywords: